BG40143A3 - Method for preparing acetamide derivatives - Google Patents

Method for preparing acetamide derivatives

Info

Publication number
BG40143A3
BG40143A3 BG065397A BG6539784A BG40143A3 BG 40143 A3 BG40143 A3 BG 40143A3 BG 065397 A BG065397 A BG 065397A BG 6539784 A BG6539784 A BG 6539784A BG 40143 A3 BG40143 A3 BG 40143A3
Authority
BG
Bulgaria
Prior art keywords
acetamide derivatives
preparing acetamide
preparing
derivatives
formulated
Prior art date
Application number
BG065397A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gerhard Satzinger
Manfred Herrmann
Edgar Fritschi
Johannes Hartenstein
Gerd Bartoszyk
Original Assignee
Goedecke Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Aktiengesellschaft filed Critical Goedecke Aktiengesellschaft
Publication of BG40143A3 publication Critical patent/BG40143A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
BG065397A 1983-05-10 1984-05-08 Method for preparing acetamide derivatives BG40143A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3317000A DE3317000C2 (de) 1983-05-10 1983-05-10 4-Oxo-thiazolidin-2-yliden-acetamid-derivate, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung von durch das Zentralnervensystem bedingten Konvulsionen

Publications (1)

Publication Number Publication Date
BG40143A3 true BG40143A3 (en) 1986-10-15

Family

ID=6198604

Family Applications (2)

Application Number Title Priority Date Filing Date
BG065397A BG40143A3 (en) 1983-05-10 1984-05-08 Method for preparing acetamide derivatives
BG069786A BG41129A3 (en) 1983-05-10 1984-05-08 Method for preparing acetamide derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG069786A BG41129A3 (en) 1983-05-10 1984-05-08 Method for preparing acetamide derivatives

Country Status (19)

Country Link
US (1) US4563471A (fr)
EP (1) EP0124911B1 (fr)
JP (1) JPS59206372A (fr)
AT (1) ATE65778T1 (fr)
AU (1) AU565799B2 (fr)
BG (2) BG40143A3 (fr)
CA (1) CA1237436A (fr)
CS (1) CS244814B2 (fr)
DD (1) DD224319A5 (fr)
DE (2) DE3317000C2 (fr)
DK (1) DK162048C (fr)
ES (2) ES532331A0 (fr)
GR (1) GR82086B (fr)
HU (1) HU190566B (fr)
IE (1) IE57372B1 (fr)
PL (2) PL142398B1 (fr)
SU (2) SU1251803A3 (fr)
YU (2) YU45183B (fr)
ZA (1) ZA843489B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269024A3 (en) * 1986-11-21 1990-05-09 Godecke Aktiengesellschaft Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
EP0715853A1 (fr) * 1991-01-10 1996-06-12 Transcend Therapeutics, Inc. Utilisation des esters de glutathione pour le traitement des désordres pulmonaires
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US6133299A (en) * 1993-02-25 2000-10-17 Warner-Lambert Company Methods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compounds
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
KR100329808B1 (ko) * 2000-01-14 2002-03-25 박호군 2-펜아실리덴-3,5-알킬치환된-1,3-티아졸리딘-4-온의 효율적 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1150985B (de) * 1961-03-06 1963-07-04 Warner Lambert Pharmaceutical Verfahren zur Herstellung von Thiazolidin-4-on-Derivaten
FR2726M (fr) * 1962-12-04 1964-08-17 Warner Lambert Pharmaceutical Amides de thiazolidinones substituées.
DE2423725C2 (de) * 1974-05-16 1982-12-30 Gödecke AG, 1000 Berlin 5-Phenyl-4-oxo-Delta 2,ALPHA-thiazolidinessigsäureester

Also Published As

Publication number Publication date
SU1251803A3 (ru) 1986-08-15
DE3317000C2 (de) 1986-09-25
YU79284A (fr) 1986-10-31
JPS6316386B2 (fr) 1988-04-08
DD224319A5 (de) 1985-07-03
AU565799B2 (en) 1987-10-01
HUT34174A (en) 1985-02-28
AU2788984A (en) 1984-11-15
EP0124911A3 (en) 1987-02-04
PL252100A1 (en) 1985-11-05
DK162048C (da) 1992-02-10
CA1237436A (fr) 1988-05-31
YU45183B (en) 1992-05-28
EP0124911A2 (fr) 1984-11-14
ES8502696A1 (es) 1985-01-16
ES532331A0 (es) 1985-01-16
JPS59206372A (ja) 1984-11-22
YU63586A (en) 1986-10-31
IE841150L (en) 1984-11-10
DK229984D0 (da) 1984-05-09
ES8502430A1 (es) 1985-01-01
CS244814B2 (en) 1986-08-14
SU1272985A3 (ru) 1986-11-23
PL247581A1 (en) 1985-07-16
DK229984A (da) 1984-11-11
PL142365B1 (en) 1987-10-31
PL142398B1 (en) 1987-10-31
BG41129A3 (en) 1987-04-15
ZA843489B (en) 1984-12-24
EP0124911B1 (fr) 1991-07-31
DE3317000A1 (de) 1984-11-15
DE3484859D1 (de) 1991-09-05
DK162048B (da) 1991-09-09
HU190566B (en) 1986-09-29
IE57372B1 (en) 1992-08-12
GR82086B (fr) 1984-12-13
US4563471A (en) 1986-01-07
ATE65778T1 (de) 1991-08-15
ES532322A0 (es) 1985-01-01

Similar Documents

Publication Publication Date Title
BG40814A3 (en) Method for preparing nucleozides
BG40655A3 (en) Method for preparing n- (bi heterocyclic)- 4- piperidineamines
BG40651A3 (en) Method for preparing (1- arylcyclobutyl) alkylamines
BG40964A3 (en) Method for preparing 8- chlor- 1, 5- benzothiazepin derivatives
BG40654A3 (en) Method for preparing cycloalkyltriazoles
BG40142A3 (en) Method for preparing piperazine derivatives
BG38787A3 (en) Method for preparing carboxyalkyl dipeptides
BG37075A3 (en) Method for preparing derivatives of proline
BG40815A3 (en) Method for preparing peptides
BG34908A3 (en) Method for preparing d- 6- n- propylergolines
BG35330A3 (en) Method for preparing 3- iodine- methylcephalosporines
BG42185A3 (en) Method for preparing pyridylic compounds
BG42355A3 (en) Method for preparing aminoguanidinic derivatives
BG40813A3 (en) Method for preparing bifunctional ester derivatives of 4- desacetyl indol- dihydroindol alkaloids
BG39976A3 (en) Method for preparing benzamides
MX161283A (es) Procedimiento para preparar((3,4-,4,5 y 5,6)piridilalquilensulfinil)benzimidazoles substituidos
BG40807A3 (en) Method for preparing n- phenylcarbamates
BG36932A3 (en) Method for preparing 1- (3- hydroxy- 4- metaxybenzoil)- 3- hydroxy- 2- pyrolidinone
BG40147A3 (en) Method for preparing heterocyclic compounds
BG40803A3 (en) Method for preparing arylcyclobutylalkylaminic derivatives
BG39639A3 (bg) Метод за получаване на 1н, 3н- пироло/1,2-с/ тиазолови производни
BG36939A3 (en) Method for preparing macrolide
BG35464A3 (en) Method preparing fluorene derivatives
BG40143A3 (en) Method for preparing acetamide derivatives
BG36935A3 (en) Method for preparing benzodiazepine compounds